Patents by Inventor John V Duncia

John V Duncia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclic and tricyclic amines as modulators of chemokine receptor activity
    Publication number: 20040209876
    Abstract: The present application describes modulators of CCR3 of formula (I):
    Type: Application
    Filed: May 11, 2004
    Publication date: October 21, 2004
    Inventors: John V. Duncia, Joseph B. Santella, Daniel S. Gardner, Dean A. Wacker
  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20040186140
    Abstract: The present application describes modulators of MCP-1 of formula (I): 1
    Type: Application
    Filed: February 11, 2004
    Publication date: September 23, 2004
    Inventors: Robert J. Cherney, Percy H. Carter, John V. Duncia, Daniel S. Gardner, Joseph B. Santella
  • Heterocyclic piperidines as modulators of chemokine receptor activity
    Publication number: 20040186097
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: March 25, 2004
    Publication date: September 23, 2004
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • Bicyclic and tricyclic amines as modulators of chemokine receptor activity
    Patent number: 6784200
    Abstract: The present application describes modulators of CCR3 of formula (I): A—E—NR1—G  (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: August 31, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: John V Duncia, Joseph B Santella, III, Daniel S Gardner, Dean A Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6780857
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: August 24, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker, Ui Tae Kim
  • Heterocyclic piperidines as modulators of chemokine receptor activity
    Patent number: 6759411
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: July 6, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • Piperidine amides as modulators of chemokine receptor activity
    Publication number: 20040082790
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: August 7, 2003
    Publication date: April 29, 2004
    Inventors: John V. Duncia, Joseph B. Santella, Dean A. Wacker, Wenqing Yao, Changsheng Zheng
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040082616
    Abstract: The present application describes N-ureidoalkyl piperidines as modulators of chemokine receptors, or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: September 11, 2003
    Publication date: April 29, 2004
    Inventors: John V. Duncia, Daniel S. Gardner, Joseph B. Santella
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040058960
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 19, 2003
    Publication date: March 25, 2004
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
    Patent number: 6706735
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: March 16, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Paul S. Watson, Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040034063
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: February 6, 2003
    Publication date: February 19, 2004
    Inventors: Soo S. Ko, George V. Delucca, John V. Duncia, Ui Tae Kim, Dean A. Wacker, Changsheng Zheng
  • Benzylcycloalkyl amines as modulators of chemokine receptor activity
    Publication number: 20040014758
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: July 3, 2003
    Publication date: January 22, 2004
    Inventors: Dean A. Wacker, John V. Duncia, Joseph B. Santella, Daniel S. Gardner
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040006107
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 24, 2002
    Publication date: January 8, 2004
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker, Ui Tae Kim
  • Bicyclic and tricyclic amines as modulators of chemokine receptor activity
    Publication number: 20040006084
    Abstract: The present application describes modulators of CCR3 of formula (I):
    Type: Application
    Filed: May 1, 2003
    Publication date: January 8, 2004
    Inventors: John V. Duncia, Joseph B. Santella, Daniel S. Gardner, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20040002515
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: October 24, 2002
    Publication date: January 1, 2004
    Inventors: Soo S. Ko, Cheryl McArdle Clark, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • Piperidine amides as modulators of chemokine receptor activity
    Patent number: 6638950
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: October 28, 2003
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: John V. Duncia, Joseph B. Santella, Dean A. Wacker, Wenqing Yao, Changsheng Zheng
  • Benzylcycloalkyl amines as modulators of chemokine receptor activity
    Patent number: 6608227
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: August 19, 2003
    Assignee: Bristol-Myers Squibb Pharma
    Inventors: Dean A Wacker, John V Duncia, Joseph B Santella, III, Daniel S Gardner
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6605623
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: August 12, 2003
    Assignee: Bristol-Myers Squibb Pharma Co.
    Inventors: Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, III, Dean A. Wacker
  • 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
    Publication number: 20030144273
    Abstract: The present application describes modulators of CCR3 of formula (I): 1
    Type: Application
    Filed: June 26, 2002
    Publication date: July 31, 2003
    Inventors: Paul S. Watson, Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker
  • Bicyclic and tricyclic amines as modulators of chemokine receptor activity
    Patent number: 6586446
    Abstract: The present application describes modulators of CCR3 of formula (I): A—E—NR1—G  (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: July 1, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: John V Duncia, Joseph B Santella, III, Daniel S Gardner, Dean A Wacker